*NOTE - some study locations are open, while others remain temporarily closed due to the impact of Coronavirus (COVID-19)*
If you are interested in taking part in this study, begin typing your location below and then select from the dropdown list. The map will update with sites within the distance you select with a list of locations below.
Please note the map below only lists study sites that are accepting online referrals. If you cannot find a site in your area please check back again as study sites can be added to the study on an ongoing basis.
Alternatively, if you wish to see the full listing of all study sites visit clinicaltrials.gov.
| Site Name | Address | Status | Distance | |
|---|---|---|---|---|
| Carolina Blood and Cancer Care | 1583 Health Care Drive
Rock Hill, SC, 29732 United States |
Recruiting | -- | Am I Eligible? |
| Center For Cancer and Blood Disorders | 6410 Rockledge Drive
Bethesda, MD, 20817 United States |
Recruiting | -- | Am I Eligible? |
| East Carolina University | 600 Moye Boulevard The Brody School Of Medicine Department Of Medicine
Greenville, NC, 27858 United States |
Not Recruiting | -- | |
| Hackensack University Medical Center | 30 Prospect Avenue
Hackensack, NJ, 07601 United States |
Recruiting | -- | Am I Eligible? |
| Innovative Clinical Research Institute | 15111 E Whittier Blvd Suite 216 Innovative Clinical Research Institute
Whittier, CA, 90603 United States |
Recruiting | -- | Am I Eligible? |
| Moffitt Cancer Center | 12902 Usf Magnolia Drive
Tampa, FL, 33612 United States |
Recruiting | -- | Am I Eligible? |
| Peninsula Cancer Institute | 110 Wimbledon Square
Newport News, VA, 23320 United States |
Recruiting | -- | Am I Eligible? |
| Sharp Memorial Hospital | 7901 Frost Street
San Diego, CA, 92123 United States |
Not Recruiting | -- | |
| University of Virginia | 1240 Lee Street
Charlottesville, VA, 22908 United States |
Recruiting | -- | Am I Eligible? |
| Western Kentucky Hematology and Oncology Group | 225 Medical Center Drive Suite 301
Paducak, KY, 42003 United States |
Recruiting | -- | Am I Eligible? |
| Yale Cancer Center | 333 Cedar Street
New Haven, CT, 06520 United States |
Recruiting | -- | Am I Eligible? |
For more information, please watch the video.
Participation in the study lasts approximately six years (and may be shorter or longer for certain patients). This includes:
• a screening period of approximately 35 days,
• an initial 24-week treatment period (which may be extended if certain criteria are met and if you continue to benefit from the treatment), and
• a follow-up period where you will be contacted approximately every 12 weeks to ask how you are doing.
The study drug being used in the COMMANDS Trial is called luspatercept, which is a protein that aims to help increase the production of red blood cells in bone marrow. Luspatercept will be administered as an injection every three weeks during the treatment period.
• a screening period of approximately 35 days,
• an initial 24-week treatment period (which may be extended if certain criteria are met and if you continue to benefit from the treatment), and
• a follow-up period where you will be contacted approximately every 12 weeks to ask how you are doing.
The study drug being used in the COMMANDS Trial is called luspatercept, which is a protein that aims to help increase the production of red blood cells in bone marrow. Luspatercept will be administered as an injection every three weeks during the treatment period.